drugset / Trial / NCT02022592
Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A goal directed , demand-driven administration of sedative drugs is an integral part of every intensive care treatment. During long-term application of sedatives, Midazolam is the most commonly used sedative in Europe. One major objective is the problem of oversedation and agitation during an intensive care treatment due to the lack of controllability of available substances. The Love-Mi RCT investigates the clinical controllability of Midazolam versus the newly available intravenous drug Lormetazepam.
Timeline
- Start
- 2014-07-17
- Primary completion
- 2019-12-12
- Completion
- 2020-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lormetazepam | Small molecule | — | Intravenous |
| Comparator | Midazolam | Small molecule | — | — |
Indications
No indication recorded.